Huber Management Launches Dedicated Corporate Bond Research Team for AI and Quantum Computing Innovators
VANCOUVER, BC, Feb. 25, 2025 /PRNewswire/ -- Huber Management is pleased to announce the establishment of a specialized corporate bond research team dedicated to analyzing and identifying investment in corporate debt opportunities within the rapidly...
G-P Expands Availability of G-P Gia™; Welcomes Leaders to the Next Era of HR
The smartest AI global HR advisor, G-P Gia, thinks like a lawyer and cuts the cost and time of compliance by up to 95%; reducing the need to outsource legal in 50 countries and 50 U.S. states BOSTON, Feb. 25, 2025 /PRNewswire/ -- G-P (Globalization...
Pudu Robotics Enhances Cleaning Efficiency at Ryugujo Spa Hotel Mikazuki Ryugutei with the Introduction of PUDU SH1
SHENZHEN, China, Feb. 25, 2025 /PRNewswire/ -- Pudu Robotics, a global leader in service robotics, is revolutionizing cleanliness standards at Ryugujo Spa Hotel Mikazuki Ryugutei in Japan, a renowned Japanese hot spring resort, with the integration...
China Yuchai International Announces Unaudited 2024 Second Half-Year and Full Year Financial Results
SINGAPORE, Feb. 25, 2025 /PRNewswire/ -- China Yuchai International Limited (NYSE: CYD) ("China Yuchai" or the "Company"), one of the largest powertrain solution manufacturers through its main operating subsidiary in China, Guangxi Yuchai Machinery...
Baidu Acquires JOYY's Live Streaming Business in China
BEIJING, Feb. 25, 2025 /PRNewswire/ -- Baidu, Inc. (NASDAQ: BIDU and HKEX: 9888 (HKD Counter) and 89888 (RMB Counter)) ("Baidu"), a leading AI company with strong Internet foundation, today announced that Baidu entered into agreements with JOYY Inc...
MicuRx Pharmaceutical: Contezolid Global Phase III Clinical Trial Safety and Efficacy Evaluation Endorsed by Data Monitoring Committee, Promising Prospects for Diabetic Foot Infection Treatment
Data Monitoring Committee (DMC) has completed the first safety and efficacy assessment of the global Phase III clinical trial, recommending continued progression as planned MRX-4 Injection followed by Contezolid Tablets demonstrated favorable safety...
WuXi XDC and LigaChem Biosciences Strengthen Partnership with Expanded MOU to Accelerate ADC Development
SHANGHAI, Feb. 25, 2025 /PRNewswire/ -- WuXi XDC Cayman Inc. ("WuXi XDC", or the "Company", stock code: 2268.HK), a leading global CRDMO (Contract Research, Development, and Manufacturing Organization) specializing in antibody-drug conjugates (ADCs)...
teamLab Phenomena Abu Dhabi Will Open on 18 April Within Saadiyat Cultural District Abu Dhabi
ABU DHABI, UAE, Feb. 25, 2025 /PRNewswire/ -- teamLab Phenomena Abu Dhabi will officially open its doors to the public in Saadiyat Cultural District Abu Dhabi on 18 April 2025, announced by the Department of Culture and Tourism—Abu Dhabi (DCT Abu...